Position paper on Braille

Position paper on NtA, Volume 2A, Chapter 1, Rev. 4 from June 2013, section 3.3

This position paper addresses the Notice to Applicants, Volume 2A - procedures for marketing authorisation, Chapter 1, Rev. 4 from June 2013. In concrete it refers to the obligation to provide the name of the medicinal product in Braille format on the packaging of simplified registered homeopathic products as explained in section “3.3 Procedure for homeopathic medicinal products”.